Actively Recruiting
Phase Not Applicable
Age: 35Years - 70Years
All Genders
ID07588087
Effect of Adding Latissimus Dorsi Myofascial Release to Scapular Proprioceptive Neuromuscular Facilitation on Pain, Disability, and Range of Motion in Adhesive Capsulitis: A Randomized Controlled Trial
Led by Ibadat International University, Islamabad · Updated on 2026-05-14
58
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of scapular proprioceptive neuromuscular facilitation (PNF) alone versus PNF combined with latissimus dorsi myofascial release in patients with stage II adhesive capsulitis. This condition involves capsular stiffness, pain, and limited shoulder movement. The study aims to compare pain, shoulder range of motion, and functional disability over a 6-week treatment period. Participants will be randomly assigned to one of two groups. The experimental group receives latissimus dorsi myofascial release for 10-15 minutes with sustained pressure holds of 90-120 seconds, followed by scapular PNF hold-relax technique (posterior elevation-anterior depression pattern) with 3 sets of 5 repetitions involving 5-7 second isometric contractions and 10-15 second stretches. The control group receives only the scapular PNF hold-relax technique with the same pattern and dosage. Both groups undergo treatment three times per week for 6 weeks. Participants' pain intensity will be measured using the Numeric Pain Rating Scale, shoulder range of motion assessed with goniometry, muscle tightness evaluated by the latissimus dorsi length test, and functional disability tracked using the Shoulder Pain and Disability Index (SPADI). Assessments occur from baseline to 6 weeks. The study uses single masking and randomized allocation, with data analyzed by IBM SPSS version 26. The total participation duration is 6 weeks.
CONDITIONS
Brief Title
Effect of Adding Latissimus Dorsi Myofascial Release to Scapular Proprioceptive Neuromuscular Facilitation on Pain, Disability, and Range of Motion in Adhesive Capsulitis
Who Can Participate
Age: 35Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
- Age between 35 and 70 years
- Both male and female participants
- Diagnosed with stage II adhesive capsulitis (frozen shoulder) with stiffness
- Shoulder pain intensity of 4 or higher on the Numeric Pain Rating Scale during movement
- Unilateral shoulder involvement
- Capsular pattern limitation with external rotation greater than abduction and internal rotation
- Positive Apley's Scratch Test
- Limited range of motion in both directions
- Symptom duration between 3 and 9 months
You will not qualify if you...
- Secondary adhesive capsulitis caused by trauma or surgery
- History of shoulder fracture or dislocation
- Bilateral frozen shoulder
- Active systemic inflammatory or neurological diseases
- Recent intra-articular corticosteroid injection within the last 3 months
- Current anticoagulation therapy or bleeding disorders
- Pregnant females
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 6 weeks
Participants receive either latissimus dorsi myofascial release combined with scapular proprioceptive neuromuscular facilitation (PNF) hold-relax technique or scapular PNF hold-relax technique alone. Treatments occur three times per week for 6 weeks.
3 visits per week for 6 weeks
Trial Site Locations
Total: 1 location
1
• Ibadat international hospital • Shaafi international hospital • South East hospital • Fauji Foundation hospital
Islamabad, Punjab Province, Pakistan, 44000
Actively Recruiting
Loading map...
Research Team
H
Hufsa Naseer, DPT, MS-PT MSK
F
Fatima Amjad, DPT, MS-PT Sports, PHD Scholar
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
A Voltage-Controlled Strategy for Modular Shono-Type Amination.
Siyuan Su, Yahui Guo, Bryan Parnitzke...
https://pubmed.ncbi.nlm.nih.gov/39401528Plyometric exercises: subsequent changes of weight-bearing symmetry, muscle strength and walking performance in children with unilateral cerebral palsy.
Ragab K Elnaggar, Mohammed F Elbanna, Waleed S Mahmoud...
https://pubmed.ncbi.nlm.nih.gov/31789302Development of a shoulder pain and disability index.
K E Roach, E Budiman-Mak, N Songsiridej...
https://pubmed.ncbi.nlm.nih.gov/11188601Manual therapy and exercise for adhesive capsulitis (frozen shoulder).
Matthew J Page, Sally Green, Sharon Kramer...
https://pubmed.ncbi.nlm.nih.gov/25157702Looking at the center of the targets helps multiple object tracking.
Hilda M Fehd, Adriane E Seiffert
https://pubmed.ncbi.nlm.nih.gov/20465338Nursing in rural, remote and isolated settings: a literature review.
Gerardina Harnett, Moninne Collins
https://pubmed.ncbi.nlm.nih.gov/36802815A formative study of the sociocultural influences on dietary behaviours during pregnancy in rural Bangladesh.
Nazrana Khaled, Anna Kalbarczyk, Eleonor Zavala...
https://pubmed.ncbi.nlm.nih.gov/39212336Tomato plant growth promotion and drought tolerance conferred by three arbuscular mycorrhizal fungi is mediated by lipid metabolism.
Wei Zhang, Kaili Xia, Zengwei Feng...
https://pubmed.ncbi.nlm.nih.gov/38430785CAR T-cell immunotherapy of MET-expressing malignant mesothelioma.
Thivyan Thayaparan, Roseanna M Petrovic, Daniela Y Achkova...
https://pubmed.ncbi.nlm.nih.gov/29209570